FTC sues big pharmacy gain managers above insulin rates The agency brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of lifestyle-preserving insulin medicines. Insurers will continue vertically integrating to maintain more income in-household, and federal scrutiny ... https://dave-s-hot-chicken-nutrit94948.qodsblog.com/30656922/everything-about-healthcare-news